Emergency Drugs vs HiX Patiënt

HiX Patiënt earns about $0 per month, while Emergency Drugs earns about $0. That is a ∞× revenue gap. Annual revenue: Emergency Drugs ≈ $0/year, HiX Patiënt ≈ $0/year. Estimates are derived from public App Store signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.

HiX Patiënt leads with about 0 estimated downloads vs 0 for Emergency Drugs - a ∞× gap. Emergency Drugs's App Store downloads are estimated from 0 ratings × the standard 1:75 ratio. HiX Patiënt's App Store downloads are estimated from 0 ratings.

Yes - both apps sit in the Medical category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.

Emergency Drugs does not appear to offer in-app purchases on its public listing. HiX Patiënt does not appear to offer in-app purchases. Monetization model: Emergency Drugs runs "Paid app ($1.99)", HiX Patiënt runs "No App Store revenue (monetizes off-store)".

Directional - typically within 2-3× of actual money earned for popular apps. The $0 for Emergency Drugs and $0 for HiX Patiënt are derived from App Store grossing rank, scraped IAP tiers, ratings volume and category benchmarks (Medical) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.

Use the search box at the bottom of this page or paste any two App Store links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.